The Dow Jones, S&P 500 and Nasdaq struggled to stay positive Tuesday morning. Palantir stock took a break on the stock market today.

The Committee for Medicinal Products for Human Use recommends marketing authorization for Pfizer and BioNTech's updated ...

Global mRNA Vaccines and Therapeutics Market is valued at approximately USD 46.8 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 16.5% over the forecast period ...

William Lai Ching-te’s first 100 days as leader of Taiwan have been evaluated not only on the basis of his handling of local affairs, but also in relation to the self-governed island’s ...

Data from the CENTERSTONE study shows single-dose Xofluza reduces transmission of influenza from an infected person to household membersThis is the first time that any antiviral used in the treatment ...

J.P. Morgan said that Taiwan Semiconductor Manufacturing's (TSM) strong sales in August suggest that the third quarter could ...

Image Source: Zacks Investment Research Spikevax, targeting the variant JN.1., is currently approved in the United States, the United Kingdom, Japan and Taiwan. Last month, the FDA approved ...

Taiwan’s healthcare market is characterized by a mix of public and private healthcare providers. The National Health Insurance (NHI) program, established in 1995, plays a central role in the ...

On Tuesday, the Medicines and Healthcare Products Regulatory Agency (MHRA) approved Moderna, Inc.‘s (NASDAQ:MRNA) updated ...

Moderna (NASDAQ:MRNA) has secured regulatory approval in the U.K. and Taiwan for an updated formulation of its COVID-19 mRNA vaccine, Spikevax. U.K. drug regulator, the Medicines and Healthcare ...

This handout picture taken and released by the Taiwan Presidential Office on June 19, 2024 shows Taiwan's President Lai Ching-te speaking during a press conference at the Presidential Office in Taipei ...